Previous close | 2.5000 |
Open | 2.5000 |
Bid | 2.3000 |
Ask | 7.5000 |
Strike | 550.00 |
Expiry date | 2024-10-18 |
Day's range | 2.5000 - 3.0400 |
Contract range | N/A |
Volume | |
Open interest | 18 |
On May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 3,250 shares of the company.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.